Wollongong Private Hospital, a Ramsay Health Care Subsidiary, Pioneers Breakthrough Heart Procedure in NSW
Reuters
May 27, 2025
Wollongong Private Hospital, a Ramsay Health Care Subsidiary, Pioneers Breakthrough Heart Procedure in NSW
Wollongong Private Hospital, a subsidiary of Ramsay Health Care Limited, has achieved a significant milestone by becoming the first center in New South Wales to offer Convergent Hybrid Therapy, a groundbreaking treatment for patients with persistent and long-standing atrial fibrillation (AF). This minimally invasive procedure combines cardiac surgery and catheter-based treatment to restore normal heart rhythm, providing new hope to individuals affected by this serious condition. Previously, patients in NSW had to travel interstate for such advanced care, but now they can access this world-class treatment closer to home. Since the launch of its cardiac surgery program in September 2021, the hospital has performed over 1,200 cardiac surgeries, establishing itself as a leader in comprehensive cardiac care. The introduction of Convergent Hybrid Therapy further enhances the hospital's capabilities, supported by the expertise of cardiologist Dr. Jayesh Gohil and cardiothoracic surgeon Dr. Mohammad Azari.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ramsay Health Care Limited published the original content used to generate this news brief on May 27, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.